Why is my transferrin (189 mg/dL) low despite normal serum iron, ferritin, total iron‑binding capacity (TIBC) and transferrin saturation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Why Is Your Transferrin Low?

Your low transferrin (189 mg/dL) most likely reflects an underlying condition causing decreased hepatic synthesis—specifically inflammation, chronic infection, malignancy, liver disease, nephrotic syndrome, or malnutrition—rather than iron deficiency, since your other iron parameters are normal. 1

Understanding the Discordance

Your iron studies show an unusual pattern that requires careful interpretation:

  • Normal serum iron (75 μg/dL) and normal transferrin saturation (28%) indicate adequate circulating iron for erythropoiesis 1
  • Normal ferritin (90.1 ng/mL) suggests adequate iron stores 1
  • Normal TIBC (265 μg/dL) reflects normal total iron-binding capacity 1
  • Low transferrin (189 mg/dL) is the isolated abnormality

Primary Causes of Isolated Low Transferrin

The CDC guidelines explicitly state that inflammation, chronic infection, malignancies, liver disease, nephrotic syndrome, and malnutrition can lower TIBC (and therefore transferrin) readings independent of iron status. 1

Key pathophysiologic mechanisms:

  • Inflammation/infection: Transferrin is a negative acute-phase reactant—it decreases during inflammatory states while ferritin (a positive acute-phase reactant) may paradoxically increase 1
  • Liver disease: Transferrin is synthesized in the liver; hepatic dysfunction reduces production 1
  • Protein-losing conditions: Nephrotic syndrome causes urinary protein loss including transferrin 1
  • Malnutrition/protein-energy wasting: Reduced hepatic synthetic capacity from inadequate protein intake 2, 3

Clinical Evaluation Algorithm

Step 1: Assess for inflammation

  • Check C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) 4
  • Review for signs of chronic infection or inflammatory conditions 1

Step 2: Evaluate hepatic function

  • Obtain comprehensive metabolic panel including albumin, total protein, liver enzymes (AST, ALT, alkaline phosphatase, bilirubin) 1
  • Low albumin alongside low transferrin suggests hepatic synthetic dysfunction or protein loss 3

Step 3: Screen for protein-losing conditions

  • Urinalysis with protein quantification (spot protein/creatinine ratio or 24-hour urine protein) to exclude nephrotic syndrome 1

Step 4: Assess nutritional status

  • Evaluate serum albumin, prealbumin, total protein, and cholesterol 3
  • Consider subjective global assessment for protein-energy wasting 3
  • Low transferrin correlates strongly with malnutrition in dialysis patients and may apply to other populations 2, 3

Step 5: Consider occult malignancy

  • Age-appropriate cancer screening if other causes excluded 1
  • Malignancies can suppress transferrin synthesis through inflammatory cytokines 1

Important Clinical Caveats

Your normal transferrin saturation (28%) is reassuring—it indicates that despite low transferrin levels, the available transferrin is adequately saturated with iron, confirming you are not iron deficient. 1 This distinguishes your situation from true iron deficiency where TSAT would typically be <16-20%. 1

The combination of low transferrin with normal TIBC deserves explanation: TIBC is calculated from transferrin (TIBC ≈ transferrin × 1.4), so they should move together. 1 If your laboratory directly measured TIBC rather than calculating it from transferrin, this could explain the discordance and warrants repeating both tests simultaneously.

Declining transferrin over time carries prognostic significance: A fall in TIBC (transferrin) >20 mg/dL over 6 months is independently associated with increased mortality risk in hemodialysis patients (hazard ratio 1.57), suggesting it reflects worsening underlying disease. 2 Serial monitoring is warranted.

What This Is NOT

  • Not iron deficiency: Your normal iron saturation, normal serum iron, and adequate ferritin exclude this 1
  • Not hemochromatosis or iron overload: Your normal-to-low iron parameters exclude this 1
  • Not a primary transferrin genetic defect: Genetic hypotransferrinemia presents in early life with severe microcytic anemia and very low/undetectable transferrin (<20% of normal), which does not match your presentation 5

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.